GTC Biotherapeutics (fka GTCB)

[biopearl]

Having an enthusiastic, diverse and competent board of directors surely serves to protect stockholder interests. Cox has assured us we are in late stage discussions with partners to refinance the company. New meds are going into clinicals in 2010, Atryn for the DIC indication interest is strong. Japan wants it too. There is enough money in the till to survive for three more weeks, that's plenty of time for the rabbit to appear. Surely if it were otherwise they would tell us and not lead us on. These late stage discussions must be about ready to close and give the company new life. The management is planning for big stock bonuses with an appreciated stock price and has reserved 10% of the company for themselves. They must be expecting good things. Is Rusty boy still in? bp